Intrathecal PKA-selective siRNA treatment blocks sustained morphine-mediated pain sensitization and antinociceptive tolerance in rats
- 1 July 2011
- journal article
- research article
- Published by Elsevier in Journal of Neuroscience Methods
- Vol. 199 (1) , 62-68
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (DA06284, GM 065465)
This publication has 40 references indexed in Scilit:
- Sustained morphine‐mediated pain sensitization and antinociceptive tolerance are blocked by intrathecal treatment with Raf‐1‐selective siRNABritish Journal of Pharmacology, 2010
- Sustained Morphine Treatment Augments Capsaicin-Evoked Calcitonin Gene-Related Peptide Release from Primary Sensory Neurons in a Protein Kinase A- and Raf-1-Dependent MannerThe Journal of Pharmacology and Experimental Therapeutics, 2009
- Intrathecal Raf-1-selective siRNA attenuates sustained morphine-mediated thermal hyperalgesiaEuropean Journal of Pharmacology, 2008
- Sustained morphine treatment augments basal CGRP release from cultured primary sensory neurons in a Raf-1 dependent mannerEuropean Journal of Pharmacology, 2008
- Underlying mechanisms of pronociceptive consequences of prolonged morphine exposurePeptide Science, 2005
- Modulation of neurotransmitter release by the second messenger-activated protein kinases: Implications for presynaptic plasticityPharmacology & Therapeutics, 2005
- Is Paradoxical Pain Induced by Sustained Opioid Exposure an Underlying Mechanism of Opioid Antinociceptive Tolerance?Neurosignals, 2005
- Cellular Mechanisms of Neurogenic InflammationThe Journal of Pharmacology and Experimental Therapeutics, 2002
- Modulation of Ion ChannelsNeuron, 1999
- Efficient Analysis of Experimental ObservationsAnnual Review of Pharmacology and Toxicology, 1980